Suterafama
4888.TTSE GROWTHPharmaceutical
Filed as STELLA PHARMA CORPORATION (2022-06–2026-06)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Heights Capital Management, Inc. | 7.84% |
| Nikko Asset Management Co., Ltd. | 5.60% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 2
| SMBC Nikko Securities Inc. | 4.61% |
| Amova Asset Management Co., Ltd. | 0.19% |
Ownership history · 12
| Holder | Ratio | Change |
|---|---|---|
| Heights Capital Management, Inc.2026-09-09 | 7.84% | -2.49pp |
| Heights Capital Management, Inc.2026-09-07 | 10.33% | +2.20pp |
| Heights Capital Management, Inc.2026-06-29 · amended | 8.13% | +2.62pp |
| Heights Capital Management, Inc.2026-06-29 · amended | 5.51% | +2.60pp |
| Heights Capital Management, Inc.2026-04-23 · amended | 2.91% | new |
| Amova Asset Management Co., Ltd.2025-11-20 · amended | 0.19% | -5.55pp |
| Amova Asset Management Co., Ltd.2025-09-19 · amended | 5.74% | new |
| Nikko Asset Management Co., Ltd.2025-05-08 · amended | 5.60% | -2.01pp |
| Nikko Asset Management Co., Ltd.2025-03-21 · amended | 7.61% | new |
| SMBC Nikko Securities Inc.2024-07-05 | 4.61% | -1.36pp |
| SMBC Nikko Securities Inc.2024-06-21 | 5.97% | -1.82pp |
| SMBC Nikko Securities Inc.2024-06-07 | 7.79% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.